查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1576662

ELISA 市場規模、佔有率、預測和趨勢分析：按類型、按技術和按應用/按最終用戶 - 2031 年世界預測

ELISA Market Size, Share, Forecast, & Trends Analysis by Type (Direct, Sandwich, Competitive) Offering (Analyzer, Software) Technology (Chemiluminescence, Colorimetry, Fluorescence) Application (Research, Diagnostic) End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 | 商品交期: 5-7個工作天內

價格

預計到 2031 年，ELISA 市場將達到 326.9 億美元，2024 年至 2031 年複合年增長率為 6.1%。

經過廣泛的二次和初步研究以及對市場情景的詳細分析，本報告對關鍵行業推動因素、阻礙因素、課題和機會進行了分析。ELISA 市場的成長是由慢性病和傳染病的增加、ELISA 在臨床環境中的使用增加、ELISA 的進步以及 ELISA 在食品行業中的使用增加所推動的。然而，假陽性的可能性和製備 ELISA 抗體的高成本限制了市場的成長。

此外，新興國家研究的成長、生物標記檢測研發活動的增加以及對疫苗開發的日益關注預計將為市場成長創造機會。然而，有關 ELISA 產品審批以及疾病診斷替代技術的可用性和利用的嚴格規定是 ELISA 市場的主要課題。

目錄

第1章簡介

第2章 研究方法

第3章 執行摘要

第4章 市場洞察

  • 概述
  • 促進因素
    • 慢性病和感染負擔沉重
    • ELISA在臨床應用的應用
    • ELISA 的進展
    • ELISA在食品工業的應用
  • 阻礙因素
    • 誤報的可能性
    • ELISA抗體製備成本高
  • 機會
    • 疫苗研發日益受到關注
    • 啟動新興國家的研究活動
    • 增加生物標記檢測的研究和開發
  • 任務
    • 嚴格的審核規定
    • 使用替代技術進行疾病診斷
  • 因子分析
  • 趨勢
    • 數字ELISA
    • 機器人和自動化
    • 多重ELISA
  • 監管分析
  • 價格分析
  • 波特五力分析

第5章 ELISA 市場類型評估

  • 概述
  • 直接法ELISA
  • 間接法ELISA
  • 夾心ELISA
  • 競爭性ELISA

第6章 ELISA 市場評估：透過提供

  • 概述
  • 試劑盒檢測
  • 分析設備
    • 按模式
      • 全自動
      • 半自動
    • 按類型
      • 光柵ELISA分析儀
      • 濾光片ELISA分析儀
  • 軟件

第7章 ELISA 市場評估：依技術分類

  • 概述
  • 化學發光ELISA
  • 比色ELISA
  • 螢光ELISA

第8章 ELISA 市場評估：依應用分類

  • 概述
  • 研究用途
    • 藥物發現/監測
      • 蛋白質定量
      • 抗體檢測
      • 生物標誌物搜尋
      • 其他藥物發現/監測應用
    • 疫苗開發
  • 診斷用途
    • 感染
    • 自身免疫性疾病
    • 腫瘤學
    • 其他診斷應用
  • 食品檢驗
  • 其他用途

第 9 章 ELISA 市場評估：按最終用戶

  • 概述
  • 製藥和生物技術公司
  • 診斷實驗室
  • CDMO□CRO
  • 學術/研究機構
  • 食品檢驗室
  • 其他最終用戶

第10章 ELISA市場評估：按地區

  • 概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 瑞士
    • 比利時
    • 其他歐洲 (RoE)
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳大利亞
    • 其他亞太地區 (RoAPAC)
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲 (RoLATAM)
  • 中東/非洲

第11章 競爭分析

  • 概述
  • 各大公司的主要成長策略
  • 競爭標桿
  • 比賽儀表板
    • 產業領導者
    • 市場差異化因素
    • 先鋒企業
    • 啟動
  • 主要企業市佔率分析/市場排名（2023年）

第12章 公司簡介（公司概況、財務概況、產品組合、策略發展現況、SWOT分析）

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche AG
  • Danaher Corporation
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Abbott Laboratories
  • bioMerieux SA
  • Revvity, Inc.
  • QuidelOrtho Corporation
  • Becton, Dickinson and Company
  • Repligen Corporation
  • BioLegend
  • Bio-Techne Corporation

（註：前5名的企業提供SWOT分析）

第13章附錄

Product Code: MRHC - 1041314

ELISA Market Size, Share, Forecast, & Trends Analysis by Type (Direct, Sandwich, Competitive) Offering (Analyzer, Software) Technology (Chemiluminescence, Colorimetry, Fluorescence) Application (Research, Diagnostic) End User-Global Forecast to 2031

The ELISA market is projected to reach $32.69 billion by 2031 at a CAGR of 6.1% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the ELISA market is driven by the increasing number of chronic and infectious diseases, growing ELISA application in clinical settings, advancements in ELISA, and the growing application of ELISA in food industries. However, the chances of false positive results and high ELISA antibody preparation costs restrain the growth of this market.

Furthermore, growing research in emerging countries, rising R&D activities for biomarker detection, and the increasing focus on vaccine development are expected to generate market growth opportunities. However, stringent regulations for ELISA product approval and the availability and usage of alternative technologies for disease diagnosis are major challenges in the ELISA market.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry in the past three to four years. The key players operating in the ELISA market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), bioMerieux SA (France), Revvity Inc. (U.S.), QuidelOrtho Corporation (U.S.), Becton, Dickinson and Company (U.S.), Repligen Corporation (U.S.), BioLegend (U.S.), and Bio-Techne Corporation (U.S.).

Among all the ELISA types studied in this report, in 2024, the indirect ELISA segment is expected to account for the largest share of 43.5% of the ELISA market. The largest share of this segment is attributed to the highly sensitive nature of indirect ELISA and the ability of ELISA to identify antigens in low-concentration solutions and the advantages of the indirect ELISA methods such as cost-effectiveness, easy operation, and most preferable for all applications. The indirect method helps in disease diagnoses such as Lyme disease and HIV, which minimizes the possibility of false positive results.

Among all the ELISA offerings studied in this report, in 2024, the kits & assays segment is expected to account for the largest share of 85.2% of the ELISA market. The larger market share of this segment is attributed to the increased use of ELISA kits & assays for biomarker detection and several chronic and infectious diseases, the availability of a wide range of assay kits for research purposes, and the wide adoption of ELISA assay kits in drug discovery.

Among all the technologies studied in this report, in 2024, the colorimetric ELISA segment is expected to account for the largest share of the ELISA market. Colorimetric ELISA is widely preferred due to its advantages such as low reagent consumption, simplicity, cost-effectiveness, broad range of applications, ease of performance, and requirement of less equipment to process. Additionally, these assays are compatible with various types of samples for complex research.

Among all the applications studied in this report, in 2024, the diagnostic applications segment is expected to account for a larger share of the ELISA market. ELISA is widely used in clinical settings for the identification of infectious diseases, allergies, cancer, autoimmune diseases, and drug discovery. High demand for ELISA kits for disease diagnosis and high adoption of self-testing pregnancy kits due to their wide availability in pharmacies at low prices support the largest share of the market.

Among all the end users studied in this report, in 2024, the diagnostic laboratories segment is expected to account for a larger share of the ELISA market. The segment's largest share is attributed to the high burden of chronic diseases, the rising number of diagnostic laboratories, and supportive initiatives to advance clinical testing capabilities in countries. For instance, according to the Science and Medicine Group (U.S.), in July 2024, Danaher announced the launch of CLIA and College of American Pathologists-certified labs for research and development in companion diagnostics and complementary diagnostics. The first two labs will be opened in Newcastle, the U.K., and the second lab will be opened in the U.S.

An in-depth analysis of the geographical scenario of the ELISA market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America is expected to account for the largest share of 37.7% of the ELISA market. The large share of this regional market is attributed to the well-established healthcare infrastructure, high investment in R&D activities, high prevalence of chronic diseases, a large number of diagnostic and pathology laboratories, and the presence of key market players in the region. For instance, in December 2022, Labcorp (U.S.) launched an anatomic pathology and histology (APH) laboratory in Los Angeles, the U.S.

Scope of the Report:

ELISA Market Assessment-by Type

  • Direct ELISA
  • Indirect ELISA
  • Sandwich ELISA
  • Competitive ELISA

ELISA Market Assessment-by Offering

  • Kits & Assays
  • Analyzers
    • By Mode
  • Fully Automated
  • Semi-automated
    • By Type
  • Optical Grating ELISA Analyzers
  • Optical Filter ELISA Analyzers
  • Software

ELISA Market Assessment-by Technology

  • Chemiluminescence ELISA
  • Colorimetric ELISA
  • Fluorescence ELISA

ELISA Market Assessment-by Application

  • Research Applications
    • Drug Discovery & Monitoring
  • Protein Quantification
  • Antibody Detection
  • Biomarker Discovery
  • Other Drug Discovery & Monitoring Applications
    • Vaccine Development
  • Diagnostic Applications
    • Infectious Diseases
    • Autoimmune Diseases
    • Oncology
    • Other Diagnostic Applications
  • Food Testing
  • Other Applications

Note: Other drug discovery & monitoring applications include toxicology studies and quality control.

Note: Other diagnostics applications include allergen testing and pregnancy testing.

Note: Other applications include agricultural, environmental, veterinary, and forensic applications.

ELISA Market Assessment-by End User

  • Hospitals & Clinics
  • Ambulatory Surgical Centres
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • CROs & CDMOs
  • Academic & Research Institutes
  • Food Laboratories
  • Other End Users

Note: Other end users include home healthcare, the agriculture industry, and the forensics industry.

ELISA Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K
    • Italy
    • Spain
    • Switzerland
    • Belgium
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Data Collection & Validation Process
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
  • 2.3. Market Sizing & Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
    • 2.3.3. Market Share Analysis
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Drivers
    • 4.2.1. High Burden of Chronic & Infectious Diseases
    • 4.2.2. Use of ELISA in Clinical Applications
    • 4.2.3. Advancements in ELISA
    • 4.2.4. Use of ELISA in the Food Industry
  • 4.3. Restraints
    • 4.3.1. Possibility of False Positive Results
    • 4.3.2. High Costs of ELISA Antibody Preparation
  • 4.4. Opportunities
    • 4.4.1. Increasing Focus on Vaccine Development
    • 4.4.2. Growing Research Activities in Developing Countries
    • 4.4.3. Increasing R&D for Biomarker Detection
  • 4.5. Challenges
    • 4.5.1. Stringent Regulations for Approval
    • 4.5.2. Use of Alternative Technologies for Disease Diagnosis
  • 4.6. Factor Analysis
  • 4.7. Trends
    • 4.7.1. Digital ELISA
    • 4.7.2. Robotics & Automation
    • 4.7.3. Multiplex ELISA
  • 4.8. Regulatory Analysis
  • 4.9. Pricing Analysis
  • 4.10. Porter's Five Forces Analysis

5. ELISA Market Assessment-by Type

  • 5.1. Overview
  • 5.2. Direct ELISA
  • 5.3. Indirect ELISA
  • 5.4. Sandwich ELISA
  • 5.5. Competitive ELISA

6. ELISA Market Assessment-by Offering

  • 6.1. Overview
  • 6.2. Kits & Assays
  • 6.3. Analyzers
    • 6.3.1. By Mode
      • 6.3.1.1. Fully Automated
      • 6.3.1.2. Semi-automated
    • 6.3.2. By Type
      • 6.3.2.1. Optical Grating ELISA Analyzers
      • 6.3.2.2. Optical Filter ELISA Analyzers
  • 6.4. Software

7. ELISA Market Assessment-by Technology

  • 7.1. Overview
  • 7.2. Chemiluminescence ELISA
  • 7.3. Colorimetric ELISA
  • 7.4. Fluorescence ELISA

8. ELISA Market Assessment-by Application

  • 8.1. Overview
  • 8.2. Research Applications
    • 8.2.1. Drug Discovery & Monitoring
      • 8.2.1.1. Protein Quantification
      • 8.2.1.2. Antibody Detection
      • 8.2.1.3. Biomarker Discovery
      • 8.2.1.4. Other Drug Discovery & Monitoring Applications
    • 8.2.2. Vaccine Development
  • 8.3. Diagnostic Applications
    • 8.3.1. Infectious Diseases
    • 8.3.2. Autoimmune Diseases
    • 8.3.3. Oncology
    • 8.3.4. Other Diagnostic Applications
  • 8.4. Food Testing
  • 8.5. Other Applications

9. ELISA Market Assessment-by End User

  • 9.1. Overview
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. Diagnostic Laboratories
  • 9.4. CDMOs & CROs
  • 9.5. Academic & Research Institutes
  • 9.6. Food Laboratories
  • 9.7. Other End Users

10. ELISA Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Switzerland
    • 10.3.7. Belgium
    • 10.3.8. Rest of Europe (RoE)
  • 10.4. Asia-Pacific
    • 10.4.1. Japan
    • 10.4.2. China
    • 10.4.3. India
    • 10.4.4. South Korea
    • 10.4.5. Australia
    • 10.4.6. Rest of Asia-Pacific (RoAPAC)
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America (RoLATAM)
  • 10.6. Middle East & Africa

11. Competition Analysis

  • 11.1. Overview
  • 11.2. Key Growth Strategies of Leading Players
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Market Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share Analysis/Market Rankings of Key Players (2023)

12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis)

  • 12.1. Thermo Fisher Scientific Inc.
  • 12.2. Merck KGaA
  • 12.3. Bio-Rad Laboratories, Inc.
  • 12.4. F. Hoffmann-La Roche AG
  • 12.5. Danaher Corporation
  • 12.6. QIAGEN N.V.
  • 12.7. Agilent Technologies, Inc.
  • 12.8. Abbott Laboratories
  • 12.9. bioMerieux SA
  • 12.10. Revvity, Inc.
  • 12.11. QuidelOrtho Corporation
  • 12.12. Becton, Dickinson and Company
  • 12.13. Repligen Corporation
  • 12.14. BioLegend
  • 12.15. Bio-Techne Corporation

(Note: SWOT analysis will be provided for the top 5 companies.)

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports

LIST OF TABLES

  • Table 1 Global ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 2 Global Direct ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 3 Global Indirect ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 4 Global Sandwich ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 5 Global Competitive ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 6 Global ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 7 Global ELISA Kits & Assays Market, by Country/Region, 2022-2031 (USD Million)
  • Table 8 Global ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 9 Global ELISA Analyzers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 10 Global Fully Automated ELISA Analyzers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 11 Global Semi-automated ELISA Analyzers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 12 Global ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 13 Global Optical Grating ELISA Analyzers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 14 Global Optical Filter ELISA Analyzers Market, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global ELISA Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 16 Global ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 17 Global Chemiluminescence-based ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Colorimetric-based ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Fluorescence-based ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 21 Global ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 22 Global ELISA Market for Research Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 23 Global ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 24 Global ELISA Market for Drug Discovery & Monitoring, by Country/Region, 2022-2031 (USD Million)
  • Table 25 Global ELISA Market for Protein Quantification, by Country/Region, 2022-2031 (USD Million)
  • Table 26 Global ELISA Market for Antibody Detection, by Country/Region, 2022-2031 (USD Million)
  • Table 27 Global ELISA Market for Biomarker Discovery, by Country/Region, 2022-2031 (USD Million)
  • Table 28 Global ELISA Market for Other Drug Discovery & Monitoring Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 29 Global ELISA Market for Vaccine Development, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Global ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 31 Global ELISA Market for Diagnostic Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global ELISA Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 33 Global ELISA Market for Autoimmune Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 34 Global ELISA Market for Oncology, by Country/Region, 2022-2031 (USD Million)
  • Table 35 Global ELISA Market for Other Diagnostic Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global ELISA Market for Food Testing, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Global ELISA Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 38 Global ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 39 Global ELISA Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 40 Global ELISA Market for Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 41 Global ELISA Market for CDMOs & CROs, by Country/Region, 2022-2031 (USD Million)
  • Table 42 Global ELISA Market for Academic & Research Institutes, by Country/Region, 2022-2031 (USD Million)
  • Table 43 Global ELISA Market for Food Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 44 Global ELISA Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global ELISA Market by Country/Region, 2022-2031 (USD Million)
  • Table 46 North America: ELISA Market, by Country, 2022-2031 (USD Million)
  • Table 47 North America: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 48 North America: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 49 North America: ELISA Analyzers Market by Mode, 2022-2031 (USD Million)
  • Table 50 North America: ELISA Analyzers Market by Type, 2022-2031 (USD Million)
  • Table 51 North America: ELISA Market by Technology, 2022-2031 (USD Million)
  • Table 52 North America: ELISA Market by Application, 2022-2031 (USD Million)
  • Table 53 North America: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 54 North America: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 55 North America: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 56 North America: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 57 U.S.: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 58 U.S.: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 59 U.S.: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 60 U.S.: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 61 U.S.: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 62 U.S.: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 63 U.S.: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 64 U.S.: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 65 U.S.: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 66 U.S.: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 67 Canada: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 68 Canada: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 69 Canada: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 70 Canada: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 71 Canada: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 72 Canada: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 73 Canada: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 74 Canada: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 75 Canada: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 76 Canada: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 77 Europe: ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 78 Europe: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 79 Europe: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 80 Europe: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 81 Europe: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 82 Europe: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 83 Europe: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 84 Europe: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 85 Europe: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 86 Europe: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 87 Europe: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 88 Germany: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 89 Germany: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 90 Germany: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 91 Germany: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 92 Germany: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 93 Germany: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 94 Germany: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 95 Germany: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 96 Germany: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 97 Germany: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 98 France: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 99 France: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 100 France: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 101 France: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 102 France: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 103 France: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 104 France: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 105 France: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 106 France: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 107 France: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 108 U.K.: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 109 U.K.: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 110 U.K.: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 111 U.K.: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 112 U.K.: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 113 U.K.: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 114 U.K.: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 115 U.K.: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 116 U.K.: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 117 U.K.: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 118 Italy: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 119 Italy: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 120 Italy: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 121 Italy: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 122 Italy: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 123 Italy: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 124 Italy: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 125 Italy: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 126 Italy: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 127 Italy: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 128 Spain: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 129 Spain: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 130 Spain: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 131 Spain: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 132 Spain: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 133 Spain: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 134 Spain: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 135 Spain: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 136 Spain: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 137 Spain: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 138 Switzerland: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 139 Switzerland: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 140 Switzerland: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 141 Switzerland: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 142 Switzerland: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 143 Switzerland: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 144 Switzerland: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 145 Switzerland: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 146 Switzerland: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 147 Switzerland: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 148 Belgium: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 149 Belgium: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 150 Belgium: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 151 Belgium: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 152 Belgium: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 153 Belgium: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 154 Belgium: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 155 Belgium: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 156 Belgium: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 157 Belgium: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 158 Rest of Europe: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 159 Rest of Europe: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 160 Rest of Europe: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 161 Rest of Europe: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 162 Rest of Europe: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 163 Rest of Europe: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 164 Rest of Europe: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 165 Rest of Europe: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 166 Rest of Europe: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 167 Rest of Europe: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 168 Asia-Pacific: ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 169 Asia-Pacific: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 170 Asia-Pacific: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 171 Asia-Pacific: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 172 Asia-Pacific: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 173 Asia-Pacific: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 174 Asia-Pacific: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 175 Asia-Pacific: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 176 Asia-Pacific: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 177 Asia-Pacific: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 178 Asia-Pacific: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 179 China: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 180 China: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 181 China: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 182 China: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 183 China: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 184 China: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 185 China: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 186 China: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 187 China: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 188 China: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 189 Japan: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 190 Japan: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 191 Japan: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 192 Japan: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 193 Japan: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 194 Japan: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 195 Japan: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 196 Japan: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 197 Japan: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 198 Japan: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 199 India: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 200 India: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 201 India: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 202 India: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 203 India: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 204 India: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 205 India: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 206 India: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 207 India: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 208 India: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 209 South Korea: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 210 South Korea: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 211 South Korea: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 212 South Korea: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 213 South Korea: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 214 South Korea: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 215 South Korea: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 216 South Korea: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 217 South Korea: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 218 South Korea: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 219 Australia: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 220 Australia: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 221 Australia: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 222 Australia: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 223 Australia: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 224 Australia: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 225 Australia: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 226 Australia: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 227 Australia: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 228 Australia: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 229 Rest of Asia-Pacific: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 230 Rest of Asia-Pacific: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 231 Rest of Asia-Pacific: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 232 Rest of Asia-Pacific: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 233 Rest of Asia-Pacific: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 234 Rest of Asia-Pacific: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 235 Rest of Asia-Pacific: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 236 Rest of Asia-Pacific: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 237 Rest of Asia-Pacific: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 238 Rest of Asia-Pacific: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 239 Latin America: ELISA Market, by Country/Region, 2022-2031 (USD Million)
  • Table 240 Latin America: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 241 Latin America: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 242 Latin America: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 243 Latin America: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 244 Latin America: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 245 Latin America: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 246 Latin America: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 247 Latin America: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 248 Latin America: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 249 Latin America: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 250 Brazil: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 251 Brazil: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 252 Brazil: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 253 Brazil: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 254 Brazil: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 255 Brazil: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 256 Brazil: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 257 Brazil: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 258 Brazil: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 259 Brazil: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 260 Mexico: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 261 Mexico: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 262 Mexico: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 263 Mexico: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 264 Mexico: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 265 Mexico: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 266 Mexico: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 267 Mexico: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 268 Mexico: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 269 Mexico: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 270 Rest of Latin America: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 271 Rest of Latin America: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 272 Rest of Latin America: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 273 Rest of Latin America: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 274 Rest of Latin America: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 275 Rest of Latin America: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 276 Rest of Latin America: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 277 Rest of Latin America: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 278 Rest of Latin America: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 279 Rest of Latin America: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 280 Middle East & Africa: ELISA Market, by Type, 2022-2031 (USD Million)
  • Table 281 Middle East & Africa: ELISA Market, by Offering, 2022-2031 (USD Million)
  • Table 282 Middle East & Africa: ELISA Analyzers Market, by Mode, 2022-2031 (USD Million)
  • Table 283 Middle East & Africa: ELISA Analyzers Market, by Type, 2022-2031 (USD Million)
  • Table 284 Middle East & Africa: ELISA Market, by Technology, 2022-2031 (USD Million)
  • Table 285 Middle East & Africa: ELISA Market, by Application, 2022-2031 (USD Million)
  • Table 286 Middle East & Africa: ELISA Market for Research Applications, by Type, 2022-2031 (USD Million)
  • Table 287 Middle East & Africa: ELISA Market for Drug Discovery & Monitoring, by Type, 2022-2031 (USD Million)
  • Table 288 Middle East & Africa: ELISA Market for Diagnostic Applications, by Type, 2022-2031 (USD Million)
  • Table 289 Middle East & Africa: ELISA Market, by End User, 2022-2031 (USD Million)
  • Table 290 Recent Developments, by Company, 2021-2024

LIST OF FIGURES

  • Figure 1 Research Process
  • Figure 2 Key Secondary Sources
  • Figure 3 Primary Research Techniques
  • Figure 4 Key Executives Interviewed
  • Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
  • Figure 6 Market Size Estimation
  • Figure 7 Global ELISA Market, by Type, 2024 Vs. 2031 (USD Million)
  • Figure 8 Global ELISA Market, by Offering, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global ELISA Market, by Technology, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global ELISA Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 11 Global ELISA Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 12 Global ELISA Market, by Geography
  • Figure 13 Impact Analysis of Market Dynamics
  • Figure 14 Global ELISA Market, by Type, 2024 Vs. 2031 (USD Million)
  • Figure 15 Global ELISA Market, by Offering, 2024 Vs. 2031 (USD Million)
  • Figure 16 Global ELISA Market, by Technology, 2024 Vs. 2031 (USD Million)
  • Figure 17 Global ELISA Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 18 Global ELISA Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 19 Global ELISA Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 20 North America: ELISA Market Snapshot
  • Figure 21 Europe: ELISA Market Snapshot
  • Figure 22 Asia-Pacific: ELISA Market Snapshot
  • Figure 23 Latin America: ELISA Market Snapshot
  • Figure 24 Key Growth Strategies Adopted by Leading Players, 2022-2024
  • Figure 25 Global ELISA Market: Competitive Benchmarking, by Offering
  • Figure 26 Global ELISA Market: Competitive Benchmarking, by Geography
  • Figure 27 Global ELISA Market: Competitive Dashboard
  • Figure 28 Global ELISA Market: Market Share Analysis/Market Rankings of Key Players (2024)
  • Figure 29 Thermo Fisher Scientific Inc.: Financial Snapshot (2024)
  • Figure 30 Merck KGaA: Financial Snapshot (2024)
  • Figure 31 Bio-Rad Laboratories, Inc.: Financial Snapshot (2024)
  • Figure 32 F. Hoffmann-La Roche AG: Financial Snapshot (2024)
  • Figure 33 Danaher Corporation: Financial Snapshot (2024)
  • Figure 34 QIAGEN N.V.: Financial Snapshot (2024)
  • Figure 35 Agilent Technologies, Inc.: Financial Snapshot (2024)
  • Figure 36 Abbott Laboratories: Financial Snapshot (2024)
  • Figure 37 bioMerieux SA: Financial Snapshot (2024)
  • Figure 38 Revvity, Inc.: Financial Snapshot (2024)
  • Figure 39 QuidelOrtho Corporation: Financial Snapshot (2024)
  • Figure 40 Becton, Dickinson and Company: Financial Snapshot (2024)
  • Figure 41 Repligen Corporation: Financial Snapshot (2024)
  • Figure 42 Bio-Techne Corporation: Financial Snapshot (2024)